153 related articles for article (PubMed ID: 32674447)
1. Topical Corticosteroids a Viable Solution for Oral Graft Versus Host Disease? A Systematic Insight on Randomized Clinical Trials.
Sava A; Piciu A; Pasca S; Mester A; Tomuleasa C
Medicina (Kaunas); 2020 Jul; 56(7):. PubMed ID: 32674447
[No Abstract] [Full Text] [Related]
2. Randomized double-blind clinical trial comparing clobetasol and dexamethasone for the topical treatment of symptomatic oral chronic graft-versus-host disease.
Noce CW; Gomes A; Shcaira V; Corrêa ME; Moreira MC; Silva Júnior A; Gonçalves LS; Garnica M; Maiolino A; Torres SR
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1163-8. PubMed ID: 24727333
[TBL] [Abstract][Full Text] [Related]
3. Treatment of oral mucosal manifestations of chronic graft-versus-host disease: dexamethasone vs. budesonide.
Zadik Y; Elad S; Shapira A; Shapira MY
Expert Opin Pharmacother; 2017 Feb; 18(3):235-242. PubMed ID: 28081677
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Topical Corticosteroids for Management of Oral Chronic Graft versus Host Disease.
Elsaadany BA; Ahmed EM; Aghbary SMH
Int J Dent; 2017; 2017():1908768. PubMed ID: 28751912
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and response to budesonide as topical corticosteroid therapy for acute intestinal GVHD.
Bertz H; Afting M; Kreisel W; Duffner U; Greinwald R; Finke J
Bone Marrow Transplant; 1999 Dec; 24(11):1185-9. PubMed ID: 10642806
[TBL] [Abstract][Full Text] [Related]
6. Improvement in oral chronic graft-versus-host disease with the administration of effervescent tablets of topical budesonide-an open, randomized, multicenter study.
Elad S; Zeevi I; Finke J; Koldehoff M; Schwerdtfeger R; Wolff D; Mohrbacher R; Levitt M; Greinwald R; Shapira MY
Biol Blood Marrow Transplant; 2012 Jan; 18(1):134-40. PubMed ID: 21703973
[TBL] [Abstract][Full Text] [Related]
7. Comparison of budesonide and dexamethasone for local treatment of oral chronic graft-versus-host disease.
Park AR; La HO; Cho BS; Kim SJ; Lee BK; Rhie JY; Gwak HS
Am J Health Syst Pharm; 2013 Aug; 70(16):1383-91. PubMed ID: 23903476
[TBL] [Abstract][Full Text] [Related]
8. Topical treatment of oral chronic graft-versus-host- disease in hematopoietic stem cell transplant recipients: A systematic review.
Haas L; Cruz-Pamplona M
J Clin Exp Dent; 2023 May; 15(5):e420-e427. PubMed ID: 37214749
[TBL] [Abstract][Full Text] [Related]
9. An Open-Label Phase II Randomized Trial of Topical Dexamethasone and Tacrolimus Solutions for the Treatment of Oral Chronic Graft-versus-Host Disease.
Treister N; Li S; Kim H; Lerman M; Sultan A; Alyea EP; Armand P; Cutler C; Ho V; Koreth J; Antin JH; Soiffer R
Biol Blood Marrow Transplant; 2016 Nov; 22(11):2084-2091. PubMed ID: 27590106
[TBL] [Abstract][Full Text] [Related]
10. Management of oral Graft versus Host Disease with topical agents: A systematic review.
Albuquerque R; Khan Z; Poveda A; Higham J; Richards A; Monteiro L; Jané-Salas E; Lopez-Lopez J; Warnakulasuriya S
Med Oral Patol Oral Cir Bucal; 2016 Jan; 21(1):e72-81. PubMed ID: 26615510
[TBL] [Abstract][Full Text] [Related]
11. Topical interventions for genital lichen sclerosus.
Chi CC; Kirtschig G; Baldo M; Brackenbury F; Lewis F; Wojnarowska F
Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD008240. PubMed ID: 22161424
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of topical forms of dexamethasone in the treatment of oral lichen planus- A systematic review.
Łukaszewska-Kuska M; Ślebioda Z; Dorocka-Bobkowska B
Oral Dis; 2022 Nov; 28(8):2063-2071. PubMed ID: 34273228
[TBL] [Abstract][Full Text] [Related]
13. Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation.
Green C; Colquitt JL; Kirby J; Davidson P; Payne E
Health Technol Assess; 2004 Nov; 8(47):iii,iv, 1-120. PubMed ID: 15527669
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroids for pneumonia.
Stern A; Skalsky K; Avni T; Carrara E; Leibovici L; Paul M
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD007720. PubMed ID: 29236286
[TBL] [Abstract][Full Text] [Related]
15. Topical budesonide for severe oral chronic graft-versus-host disease.
Zadik Y; Nakdimon I; Meyerowitz C; Shapira MY; Elad S
Am J Health Syst Pharm; 2014 Feb; 71(3):181-2. PubMed ID: 24429008
[No Abstract] [Full Text] [Related]
16. Formulation of budesonide mouthwash for the treatment of oral chronic graft-versus-host disease.
Van Schandevyl G; Bauters T
J Oncol Pharm Pract; 2016 Feb; 22(1):82-5. PubMed ID: 25411262
[TBL] [Abstract][Full Text] [Related]
17. [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment].
Elad S; Levitt M; M Y S
Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):19-27, 72. PubMed ID: 19263864
[TBL] [Abstract][Full Text] [Related]
18. Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease.
Wolff D; Anders V; Corio R; Horn T; Morison WL; Farmer E; Vogelsang GB
Photodermatol Photoimmunol Photomed; 2004 Aug; 20(4):184-90. PubMed ID: 15238096
[TBL] [Abstract][Full Text] [Related]
19. The role of topical corticosteroids in bullous pemphigoid in the elderly.
Joly P; Fontaine J; Roujeau JC
Drugs Aging; 2005; 22(7):571-6. PubMed ID: 16038572
[TBL] [Abstract][Full Text] [Related]
20. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
